Emtricitabine

drug-information.ru

|Emtricitabine

Drugs search, click the first letter of a drug name:


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home

Emtricitabine


Generic Name: Emtricitabine Capsules (em-trye-SYE-ta-been)
Brand Name: Emtriva

Emtricitabine may infrequently cause severe, sometimes fatal, side effects. A metabolic disorder, called lactic acidosis, or severe liver problems may occur. Tell your doctor immediately if you experience dark urine, unusual fatigue, yellowing of eyes or skin, rapid breathing, muscle aches, stomach or abdominal pain, or unusual drowsiness.

Emtricitabine has not been approved to treat hepatitis B infection. Safety and effectiveness of Emtricitabine have not been established in patients who have both HIV and hepatitis B. Severe worsening of hepatitis B has been reported in patients who have stopped taking Emtricitabine . Lab tests, including liver function tests, may be performed for several months after you stop taking Emtricitabine if you have both HIV and hepatitis B.


Emtricitabine is used for:

Treating HIV infection. It must be used in combination with other HIV medicines.

Emtricitabine is an antiviral medicine. It works by blocking a protein that helps HIV spread, which reduces HIV levels in the blood.

Do NOT use Emtricitabine if:

  • you are allergic to any ingredient in Emtricitabine

Contact your doctor or health care provider right away if any of these apply to you.

Before using Emtricitabine :

Some medical conditions may interact with Emtricitabine . Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

  • if you are pregnant, planning to become pregnant, or are breast-feeding
  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if you have allergies to medicines, foods, or other substances
  • if you have chronic hepatitis B, kidney problems, lactic acidosis, liver problems (eg, enlarged liver), or abnormal liver function test results

Some MEDICINES MAY INTERACT with Emtricitabine . However, no specific interactions with Emtricitabine are known at this time.

This may not be a complete list of all interactions that may occur. Ask your health care provider if Emtricitabine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Emtricitabine :

Use Emtricitabine as directed by your doctor. Check the label on the medicine for exact dosing instructions. Check the label on the medicine for exact dosing instructions.

  • Emtricitabine may be taken with or without food.
  • Emtricitabine comes with an additional patient leaflet. Read it carefully and reread it each time you get Emtricitabine refilled. Ask your doctor or pharmacist any questions that you may have about Emtricitabine .
  • Take Emtricitabine at the same time each day to keep a constant amount of medicine in your body. Do not skip doses of Emtricitabine .
  • If you miss a dose of Emtricitabine , take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once. It is important not to miss doses of Emtricitabine .

Ask your health care provider any questions you may have about how to use Emtricitabine .

Important safety information:

  • Emtricitabine may cause dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Emtricitabine . Using Emtricitabine alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.
  • Do not exceed the recommended dose without checking with your doctor. Exceeding the prescribed dose of Emtricitabine may not provide additional benefits and may increase the risks of side effects.
  • Do not stop taking Emtricitabine (or other HIV medicines) without first checking with your doctor. This may cause the amount of the virus to increase or may make the virus harder to treat.
  • Emtricitabine is not a cure for HIV infection and patients may continue to acquire illnesses and infections associated with HIV. Remain under the care of your doctor.
  • Emtricitabine offers no protection from the transmission of HIV to others through sexual contact or blood contamination. Use barrier forms of contraception (eg, condoms) if you are infected with HIV. Do not share needles, other injection equipment, or personal items such as toothbrushes or razor blades.
  • Emtricitabine may not prevent other infections. If your health changes, check with your doctor.
  • LAB TESTS, including liver and kidney function, may be performed to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.
  • Use Emtricitabine with extreme caution in CHILDREN younger than 3 months of age. Safety and effectiveness in this age group have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Emtricitabine during pregnancy. HIV-infected mothers should not breast-feed their infants because of the risk of transmitting the HIV infection or Emtricitabine .

Possible side effects of Emtricitabine :

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Abnormal skin sensation; change in color of skin on palms or soles of feet; changes in body fat; cough; depression; diarrhea; dizziness; headache; indigestion; joint or muscle pain; nausea; runny nose; sleeplessness; stomach pain; vomiting; weakness or lack of energy.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dark urine; fever, chills, or sore throat; rapid breathing; severe or persistent cough; severe weakness; unusual fatigue; yellowing of the eyes or skin.

This is not a complete list of all side effects that may occur. If you have questions or need medical advice about side effects, contact your doctor or health care provider. You may report side effects to the FDA at 1-800-FDA-1088 (1-800-332-1088) or at http://www.fda.gov/medwatch.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center ( http://www.aapcc.org/findyour.htm), or emergency room immediately.

Proper storage of Emtricitabine :

Store Emtricitabine at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Emtricitabine out of the reach of children and away from pets.

General information:

  • If you have any questions about Emtricitabine , please talk with your doctor, pharmacist, or other health care provider.
  • Emtricitabine is to be used only by the patient for whom it is prescribed. Do not share it with other people.
  • If your symptoms do not improve or if they become worse, check with your doctor.

This information is a summary only. It does not contain all information about Emtricitabine . If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: November 1, 2006
Database Edition 06.4.1.002
Copyright © 2006 Wolters Kluwer Health, Inc.




Where can I get more information about Emtricitabine ? We recommend to use www.Drugs.com

Typical mistypes for Emtricitabine
wmtricitabine, smtricitabine, dmtricitabine, rmtricitabine, 4mtricitabine, 3mtricitabine, entricitabine, ektricitabine, ejtricitabine, emrricitabine, emfricitabine, emgricitabine, emyricitabine, em6ricitabine, em5ricitabine, emteicitabine, emtdicitabine, emtficitabine, emtticitabine, emt5icitabine, emt4icitabine, emtrucitabine, emtrjcitabine, emtrkcitabine, emtrocitabine, emtr9citabine, emtr8citabine, emtrixitabine, emtrivitabine, emtrifitabine, emtriditabine, emtricutabine, emtricjtabine, emtricktabine, emtricotabine, emtric9tabine, emtric8tabine, emtricirabine, emtricifabine, emtricigabine, emtriciyabine, emtrici6abine, emtrici5abine, emtricitzbine, emtricitsbine, emtricitwbine, emtricitqbine, emtricitavine, emtricitanine, emtricitahine, emtricitagine, emtricitabune, emtricitabjne, emtricitabkne, emtricitabone, emtricitab9ne, emtricitab8ne, emtricitabibe, emtricitabime, emtricitabije, emtricitabihe, emtricitabinw, emtricitabins, emtricitabind, emtricitabinr, emtricitabin4, emtricitabin3, mtricitabine, etricitabine, emricitabine, emticitabine, emtrcitabine, emtriitabine, emtrictabine, emtriciabine, emtricitbine, emtricitaine, emtricitabne, emtricitabie, emtricitabin, metricitabine, etmricitabine, emrticitabine, emtircitabine, emtrciitabine, emtriictabine, emtrictiabine, emtriciatbine, emtricitbaine, emtricitaibne, emtricitabnie, emtricitabien, eemtricitabine, emmtricitabine, emttricitabine, emtrricitabine, emtriicitabine, emtriccitabine, emtriciitabine, emtricittabine, emtricitaabine, emtricitabbine, emtricitabiine, emtricitabinne, emtricitabinee, etc.



© Copyright by drug-information.ru 2001-2019. All rights reserved